Aptorum Group Limited (APM)
NASDAQ: APM · Real-Time Price · USD
0.7820
-0.0032 (-0.41%)
At close: Jul 10, 2026, 4:00 PM EDT
0.7950
+0.0130 (1.66%)
After-hours: Jul 10, 2026, 7:39 PM EDT
Aptorum Group Market Cap
Aptorum Group has a market cap or net worth of $6.37 million as of July 10, 2026. Its market cap has decreased by -10.92% in one year.
Market Cap
6.37M
Enterprise Value
6.36M
1-Year Change
-10.92%
Ranking
Category
Stock Price
$0.78
Market Cap Chart
Since December 18, 2018, Aptorum Group's market cap has decreased from $415.79M to $6.37M, a decrease of -98.47%. That is a compound annual growth rate of -42.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 6.37M | -26.23% |
| Dec 31, 2025 | 8.63M | -45.03% |
| Dec 31, 2024 | 15.70M | 23.78% |
| Dec 29, 2023 | 12.69M | -35.41% |
| Dec 30, 2022 | 19.64M | -63.24% |
| Dec 31, 2021 | 53.44M | -36.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XTL Biopharmaceuticals | 6.54M |
| Acurx Pharmaceuticals | 6.45M |
| Addex Therapeutics | 6.36M |
| BioAtla | 6.34M |
| Curanex Pharmaceuticals | 6.32M |
| Pulmatrix | 6.28M |
| Xenetic Biosciences | 6.27M |
| AIM ImmunoTech | 6.25M |